Stock listing
NASDAQ:SWTX SpringWorks Therapeutics Inc Stock
Follow SpringWorks Therapeutics Inc into a list and get an email when it puts out news.
Last close · NASDAQ:SWTX
$46.99 USD
Close on Jun 30, 2025 · No longer trades
- Lowest – highest close
- $17.74 – $93.59 USDSince Sep 13, 2019 · lowest Nov 14, 2019 · highest Feb 24, 2021
Delisted NASDAQ:SWTX no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:SWTX
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
SpringWorks Therapeutics Inc on 6ix
- Calls
- 3 calls with a replay · 3 with a transcript · latest Nov 12, 2024
- Decks
- 5 decks · latest Nov 28, 2023
Events
| Call | When | Status |
|---|---|---|
| SpringWorks Therapeutics (SWTX) Q3 2024 Earnings Call | Tue, Nov 12, 2024 · 8:30 AM ET | Replay |
| SpringWorks Therapeutics (SWTX) Q2 2024 Earnings Call | Wed, Aug 07, 2024 · 8:30 AM ET | Replay |
| SpringWorks Therapeutics (SWTX) Q1 2024 Earnings Call | Thu, May 02, 2024 · 8:30 AM ET | Replay |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Corporate Update (November 2023) | Corporate update | 24 slides | Nov 28, 2023 |
| Corporate Update (November 2023) | Corporate update | 23 slides | Nov 17, 2023 |
| Technical Presentation (September 2022) | Technical | 17 slides | Sep 12, 2022 |
| Investor Day (June 2022) | Investor day | 87 slides | Jun 10, 2022 |
| Investor Presentation (December 2019) | Investor deck | 35 slides | Dec 9, 2019 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Carl Gordon Other companies: ADARx Pharmaceuticals, Inc. (Co-head Global Private Equity at OrbiMed Advisors · Since at least Sep 24, 2026); Electra Therapeutics, Inc. (Director · Since at least Sep 18, 2026); BlossomHill Therapeutics, Inc. (Board Member · Since at least Aug 6, 2026); Scribe Therapeutics Inc. (Director · Since at least Jul 23, 2026); Compass Therapeutics, Inc. (Founding Member, Managing Partner, and Co-Head of Global Private Equity, OrbiMed Advisors LLC · Since at least Jun 17, 2020); Keros Therapeutics, Inc. (Director · Since at least Apr 7, 2020); MBX Biosciences, Inc. (Director · Sep 12, 2024 – Feb 14, 2025 · Past); ArriVent BioPharma, Inc. (Director · Jan 25, 2024 – Jan 30, 2024 · Past); Theseus Pharmaceuticals Inc (Director · Oct 6, 2021 – Feb 14, 2024 · Past); Disc Medicine, Inc. (Director · Feb 5, 2021 – Oct 4, 2021 · Past); Terns Pharmaceuticals, Inc. (Director · Feb 4, 2021 – Jul 15, 2024 · Past); Kinnate Biopharma Inc (Director · Dec 2, 2020 – Apr 3, 2024 · Past); Adicet Bio, Inc. (Director · Sep 15, 2020 – Aug 21, 2024 · Past); ORIC Pharmaceuticals, Inc. (Director · Apr 23, 2020 – Jun 16, 2021 · Past); Prevail Therapeutics Inc (Director · Jun 19, 2019 – Jan 22, 2021 · Past); Turning Point Therapeutics Inc (Director · Apr 16, 2019 – Jun 15, 2020 · Past); Alector, Inc. (Director · Feb 6, 2019 – May 10, 2019 · Past); Armo Biosciences Inc. (Director · Jan 25, 2018 – Jun 22, 2018 · Past); X4 Pharmaceuticals, Inc. (Director · Nov 15, 2017 – Jun 5, 2018 · Past); Cartesian Therapeutics, Inc. (Director · Jun 21, 2016 – Jun 27, 2016 · Past); Intellia Therapeutics, Inc. (Director · May 5, 2016 – May 18, 2017 · Past); Acceleron Pharma Inc (Director · Sep 18, 2013 – Sep 18, 2013 · Past); Pacira BioSciences, Inc. (Director · Feb 2, 2011 – Feb 8, 2011 · Past); Amarin Corporation plc (Director · Dec 30, 2010 – Sep 4, 2012 · Past); BioCryst Pharmaceuticals, Inc. (Director · May 17, 2006 – May 17, 2006 · Past) | Director · Sep 12, 2019 – Sep 12, 2019 · Past |
| Daniel Lynch Other companies: TCGX Acquisition Corp. (Chairman of the TriGemX Bio Board of Directors · Since Nov 9, 2026); Xilio Therapeutics, Inc. (Director · Oct 21, 2021 – Oct 21, 2021 · Past); 2Seventy Bio Inc (Director · Oct 18, 2021 – Jun 13, 2023 · Past); Omega Alpha SPAC (Director · Jan 6, 2021 – Jan 6, 2021 · Past); Translate Bio Inc (Director · Jun 27, 2018 – Dec 31, 2020 · Past); Sesen Bio Inc (Director · Jun 12, 2018 – Jun 19, 2019 · Past); Surface Oncology Inc (Director · Apr 18, 2018 – Jun 10, 2020 · Past); Blueprint Medicines Corp (Director · Apr 30, 2015 – Jun 24, 2020 · Past); Eleven Biotherapeutics Inc (Director · Feb 5, 2014 – May 19, 2017 · Past); BIND Therapeutics Inc (Director · Sep 19, 2013 – Jun 9, 2015 · Past); Bluebird bio Inc (Director · Jun 18, 2013 – Nov 11, 2021 · Past) | Director · Since at least Sep 12, 2019 |
| Alan Fuhrman Other companies: Tyra Biosciences, Inc. (Chief Financial Officer · Since at least Jan 1, 2023); Checkmate Pharmaceuticals Inc (Director · Aug 6, 2020 – May 31, 2022 · Past); Esperion Therapeutics, Inc. (Director · Mar 16, 2020 – May 23, 2024 · Past); Synlogic Inc (Chief Financial Officer · Sep 30, 2015 – Mar 11, 2016 · Past); Loxo Oncology Inc (Director · Jan 12, 2015 – Feb 15, 2019 · Past); Ambit Biosciences Corp (Chief Financial Officer · May 15, 2013 – Nov 10, 2014 · Past); Achieve Life Sciences, Inc. (Senior Vice President & CFO · Dec 16, 2005 – Mar 18, 2008 · Past) | Director · Since at least Sep 12, 2019 |
| Deval Patrick Other companies: Toast, Inc. (Board Member · Since at least Sep 21, 2021); Twilio Inc. (Director · Since at least Jan 13, 2021); Cerevel Therapeutics Holdings Inc (Director · Jan 20, 2021 – Aug 1, 2024 · Past); Environmental Impact Acquisition Corp. (Director · Jan 13, 2021 – Jan 13, 2021 · Past); American Well Corporation (Director · Sep 16, 2020 – Jun 22, 2023 · Past); Global Blood Therapeutics Inc (Director · Aug 11, 2015 – Oct 5, 2022 · Past) | Director · Sep 12, 2019 – Sep 12, 2019 · Past |
| Martin Mackay Other companies: Kailera Therapeutics, Inc. (Co-Founder and Chair of Board, Rallybio Corporation · Since at least Apr 16, 2026); Rallybio Corporation (Co-Founder and Chairman · Since at least Jul 28, 2021); Charles River Laboratories International, Inc. (Director · Since at least Jul 1, 2017); 5 01 Acquisition Corp (Director · Oct 13, 2020 – Oct 16, 2020 · Past); Alexion Pharmaceuticals Inc (EVP & Global Head of R&D · May 13, 2013 – Feb 27, 2017 · Past); Pfizer, Inc. (Senior Vice President · Sep 30, 2008 – May 14, 2010 · Past) | Director · Since at least Jul 29, 2024 |
| Freda Lewis-Hall Other companies: CDT Equity Inc. (Director · Since at least Sep 22, 2023); Pyxis Oncology, Inc. (Director · Since at least Oct 7, 2021); EXACT Sciences Corporation (Director · Apr 22, 2020 – Jun 8, 2023 · Past); 1Life Healthcare Inc (Director · Jan 30, 2020 – Feb 22, 2023 · Past); Pfizer, Inc. (Executive Vice President · Feb 22, 2018 – Feb 27, 2019 · Past) | Director · Since at least Mar 29, 2019 |
| Stephen P Squinto Other companies: Chemomab Therapeutics Ltd. (Director · Mar 16, 2021 – Apr 19, 2021 · Past); Compass Therapeutics, Inc. (Director · Jun 17, 2020 – Feb 18, 2022 · Past); Passage Bio, Inc. (Head of Research and Dev, Director · Feb 27, 2020 – Feb 27, 2020 · Past); Audentes Therapeutics Inc (Director · Jul 19, 2016 – Oct 8, 2017 · Past); Alexion Pharmaceuticals Inc (EVP, Chief Global Ops. Officer · Jan 9, 2006 – Oct 27, 2014 · Past) | Director · Mar 29, 2019 – May 19, 2022 · Past |
| Jeffrey Lawrence Schwartz Other companies: Kestra Medical Technologies, Ltd. (Director · Since at least Mar 6, 2025); Rapid Micro Biosystems, Inc. (Director · Jul 14, 2021 – May 23, 2024 · Past); BCLS Acquisition Corp (Chief Executive Officer, Director · Oct 21, 2020 – Oct 26, 2020 · Past); Dicerna Pharmaceuticals Inc (Director · Dec 18, 2017 – Dec 18, 2017 · Past) | Director · Mar 29, 2019 – May 24, 2023 · Past |
| Julie Hambleton Other companies: Erasca, Inc. (Board Director · Since at least Jul 15, 2021); IGM Biosciences Inc (Director · Since at least Sep 17, 2019); IDEAYA Biosciences, Inc. (SVP, Chief Medical Officer · May 22, 2019 – Feb 21, 2020 · Past); Five Prime Therapeutics Inc (EVP & Chief Medical Officer · Sep 17, 2013 – Nov 11, 2015 · Past) | Director · Since at least May 20, 2020 |
| Carlos Albán Other companies: Solventum Corporation (Director · Since at least Apr 1, 2024); AbbVie Inc. (Vice Chairman · Dec 7, 2012 – Nov 16, 2020 · Past); Abbott Laboratories (Senior Vice President · Oct 15, 2009 – Dec 1, 2012 · Past) | Director · Since at least Jul 14, 2022 |
All 23 people
| Person | Seat |
|---|---|
| Michael F Burgess Other companies: Turnstone Biologics Corp. (Interim Chief Medical Officer, Director · Jul 20, 2023 – Oct 16, 2023 · Past); Synlogic Inc (Director · Feb 3, 2020 – Jun 22, 2023 · Past) | Head of Research & Development · May 10, 2021 – Jul 18, 2022 · Past |
| Michael Nofi Other companies: Edgewise Therapeutics, Inc. (Chief Financial Officer · Since at least Nov 10, 2025); Perfumania Holdings Inc (CFO · Apr 28, 2017 – Apr 28, 2017 · Past) | Chief Accounting Officer · Since at least Nov 11, 2019 |
| Perier I Francis Jr Other companies: Clinical Data Inc (Vice President · Apr 13, 2011 – Apr 13, 2011 · Past); Forest Laboratories Inc (EVP - Chief Financial Officer · Dec 8, 2006 – Jul 1, 2014 · Past) | Chief Financial Officer · Since at least Sep 12, 2019 |
| Saqib Islam Other companies: Passage Bio, Inc. (Director · Since at least May 27, 2021); ARS Pharmaceuticals, Inc. (Director · Since at least Dec 3, 2020) | Chief Executive Officer, Director · Since at least Jan 7, 2021 |
| Badreddin Edris Other companies: Edgewise Therapeutics, Inc. (Director and Co-Founder · Since at least Mar 25, 2021) | Chief Operating Officer · Since at least Sep 12, 2019 |
| Bhavesh Ashar Other companies: Tyra Biosciences, Inc. (Chief Operating Officer · Since at least Dec 1, 2025) | Chief Commercial Officer · Since at least Mar 22, 2021 |
| Herschel S Weinstein Other companies: Forest Laboratories Inc (SVP General Counsel · Jan 30, 2006 – Oct 23, 2013 · Past) | General Counsel & Secretary · Since at least Jan 27, 2020 |
| Michael Greco Other companies: Veradermics, Incorporated (General Counsel · Since at least Feb 3, 2026) | General Counsel & Secretary · Sep 12, 2019 – Sep 12, 2019 · Past |
| Daniel Pichl | Chief People Officer · Since at least Aug 3, 2020 |
| James Cassidy | Chief Medical Officer · Since at least Oct 6, 2022 |
| Jens Renstrup | Chief Medical Officer · Sep 12, 2019 – Jan 7, 2021 · Past |
| L Mary Smith | Chief Development Officer · Sep 12, 2019 – Jan 4, 2024 · Past |
| Tai-An Lin | Chief Scientific Officer · Since at least Sep 11, 2023 |
Log in to ask 6ix AI your own questions about SpringWorks Therapeutics Inc.